Erythropoietin mediates re-programming of endotoxin-tolerant macrophages through PI3K/AKT signaling and protects mice against secondary infection
暂无分享,去创建一个
Fengxue Zhang | Tingting Liu | Zhiren Zhang | Zhiyu Wang | B. Luo | Jialin Jia | Yu Liu | Xue Zhang | D. He | F. Liang | Jie Mei | Wenhua Li | Bangwei Luo
[1] X. Wang,et al. Multiple mechanisms of salidroside on anti-tumor effects. , 2021, European review for medical and pharmacological sciences.
[2] Fengxue Zhang,et al. Erythropoietin Promotes Infection Resolution and Lowers Antibiotic Requirements in E. coli- and S. aureus-Initiated Infections , 2021, Frontiers in Immunology.
[3] Yu Zheng,et al. Salidroside: A review of its recent advances in synthetic pathways and pharmacological properties. , 2021, Chemico-biological interactions.
[4] Qun Xia,et al. Salidroside improves angiogenesis-osteogenesis coupling by regulating the HIF-1α/VEGF signalling pathway in the bone environment. , 2020, European journal of pharmacology.
[5] W. Ju,et al. Salidroside inhibits platelet function and thrombus formation through AKT/GSK3β signaling pathway , 2020, Aging.
[6] M. Singer,et al. Sepsis therapies: learning from 30 years of failure of translational research to propose new leads , 2020, EMBO molecular medicine.
[7] X. Ju,et al. Advances in Research on Anticancer Properties of Salidroside , 2020, Chinese Journal of Integrative Medicine.
[8] Hong Shi,et al. Anti-inflammatory effects of Rhodiola rosea L.: A review. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[9] X. Fang,et al. Salidroside and FG-4592 ameliorate high glucose-induced glomerular endothelial cells injury via HIF upregulation. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[10] N. Kissoon,et al. The global burden of sepsis: barriers and potential solutions , 2018, Critical Care.
[11] A. Perkins,et al. EPO does not promote interaction between the erythropoietin and beta-common receptors , 2018, Scientific Reports.
[12] Lin Qiu,et al. PI3K/AKT-mediated upregulation of WDR5 promotes colorectal cancer metastasis by directly targeting ZNF407 , 2017, Cell Death & Disease.
[13] T. Hawn,et al. MARCO variants are associated with phagocytosis, pulmonary tuberculosis susceptibility and Beijing lineage , 2016, Genes and Immunity.
[14] C. Thiemermann,et al. Flipping the molecular switch for innate protection and repair of tissues: Long-lasting effects of a non-erythropoietic small peptide engineered from erythropoietin. , 2015, Pharmacology & therapeutics.
[15] V. Nizet,et al. Human monocytes undergo functional re-programming during sepsis mediated by hypoxia-inducible factor-1α. , 2015, Immunity.
[16] B. Wei,et al. Activation of vascular endothelial growth factor receptor-3 in macrophages restrains TLR4-NF-κB signaling and protects against endotoxin shock. , 2014, Immunity.
[17] R. Bellomo,et al. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012. , 2014, JAMA.
[18] J. Marshall,et al. Why have clinical trials in sepsis failed? , 2014, Trends in molecular medicine.
[19] P. Enkhbaatar,et al. The Immunobiology of Toll-Like Receptor 4 Agonists: From Endotoxin Tolerance to Immunoadjuvants , 2013, Shock.
[20] Ivana V. Yang,et al. Role of Macrophage Receptor with Collagenous Structure in Innate Immune Tolerance , 2013, The Journal of Immunology.
[21] C. O. Kim,et al. Anti-vascular endothelial growth factor antibody attenuates inflammation and decreases mortality in an experimental model of severe sepsis , 2013, Critical Care.
[22] Yihai Cao. Erythropoietin in cancer: a dilemma in risk therapy , 2013, Trends in Endocrinology & Metabolism.
[23] J. D. de Fijter,et al. Randomized Trial of Short‐Course High‐Dose Erythropoietin in Donation After Cardiac Death Kidney Transplant Recipients , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[24] T. Standiford,et al. Cathelicidin-Related Antimicrobial Peptide Is Required for Effective Lung Mucosal Immunity in Gram-Negative Bacterial Pneumonia , 2012, The Journal of Immunology.
[25] R. Choi,et al. Salidroside stimulates the accumulation of HIF-1α protein resulted in the induction of EPO expression: a signaling via blocking the degradation pathway in kidney and liver cells. , 2012, European journal of pharmacology.
[26] H. Tilg,et al. Erythropoietin Contrastingly Affects Bacterial Infection and Experimental Colitis by Inhibiting Nuclear Factor-κB-Inducible Immune Pathways , 2011, Immunity.
[27] Max Gassmann,et al. Macrophages as novel target cells for erythropoietin , 2010, Haematologica.
[28] J. D. Young,et al. Bench to bedside: A role for erythropoietin in sepsis , 2010, Critical care.
[29] T. Rogers,et al. Major Differences Exist in Frequencies of Virulence Factors and Multidrug Resistance between Community and Nosocomial Escherichia coli Bloodstream Isolates , 2010, Journal of Clinical Microbiology.
[30] S. Biswas,et al. Endotoxin tolerance: new mechanisms, molecules and clinical significance. , 2009, Trends in immunology.
[31] D. Iliopoulos,et al. The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs. , 2009, Immunity.
[32] Juan Zhang,et al. Salidroside protects cardiomyocyte against hypoxia-induced death: a HIF-1alpha-activated and VEGF-mediated pathway. , 2009, European journal of pharmacology.
[33] R. Kingston,et al. WDR5 Interacts with Mixed Lineage Leukemia (MLL) Protein via the Histone H3-binding Pocket* , 2008, Journal of Biological Chemistry.
[34] Xian-feng Chen,et al. Up-regulation of IRAK-M is essential for endotoxin tolerance induced by a low dose of lipopolysaccharide in Kupffer cells. , 2008, The Journal of surgical research.
[35] G. Piraino,et al. Peroxisome proliferator activated receptor γ is not necessary for the development of LPS‐induced tolerance in macrophages , 2008, Immunology.
[36] J. Luyendyk,et al. Genetic Analysis of the Role of the PI3K-Akt Pathway in Lipopolysaccharide-Induced Cytokine and Tissue Factor Gene Expression in Monocytes/Macrophages1 , 2008, The Journal of Immunology.
[37] Ji Zhang,et al. EPOR signaling: 450 million years' history , 2007 .
[38] E. Sherwood,et al. ENDOTOXIN PRETREATMENT IMPROVES BACTERIAL CLEARANCE AND DECREASES MORTALITY IN MICE CHALLENGED WITH STAPHYLOCOCCUS AUREUS , 2007, Shock.
[39] Simmie L. Foster,et al. Gene-specific control of inflammation by TLR-induced chromatin modifications , 2007, Nature.
[40] A. Sytkowski. Does Erythropoietin Have a Dark Side? Epo Signaling and Cancer Cells , 2007, Science's STKE.
[41] Jun Asai,et al. Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing. , 2007, The American journal of pathology.
[42] E. Sherwood,et al. IMPROVED BACTERIAL CLEARANCE AND DECREASED MORTALITY CAN BE INDUCED BY LPS TOLERANCE AND IS NOT DEPENDENT UPON IFN-&ggr; , 2007, Shock.
[43] J. Myklebust,et al. PI3K/Akt‐dependent Epo‐induced signalling and target genes in human early erythroid progenitor cells , 2006, British journal of haematology.
[44] Seppo Yla-Herttuala,et al. Vascular endothelial growth factor-C accelerates diabetic wound healing. , 2006, The American journal of pathology.
[45] B. Zingarelli,et al. THE PHOSPHATIDYLINOSITOL 3 KINASE PATHWAY REGULATES TOLERANCE TO LIPOPOLYSACCHARIDE AND PRIMING RESPONSES TO STAPHYLOCOCCUS AUREUS AND LIPOPOLYSACCHARIDE , 2006, Shock.
[46] S. Isenmann,et al. Erythropoietin promotes regeneration of adult CNS neurons via Jak2/Stat3 and PI3K/AKT pathway activation , 2005, Molecular and Cellular Neuroscience.
[47] K. Maiese,et al. New avenues of exploration for erythropoietin. , 2005, JAMA.
[48] J. Kimpen,et al. PLASMA VASCULAR ENDOTHELIAL GROWTH FACTOR IN SEVERE SEPSIS , 2005, Shock.
[49] N. Mackman,et al. PI3K-Akt Pathway Suppresses Coagulation and Inflammation in Endotoxemic Mice , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[50] S. Koyasu,et al. PI3K and negative regulation of TLR signaling. , 2003, Trends in immunology.
[51] Charles A. Janeway,et al. IRAK-M Is a Negative Regulator of Toll-like Receptor Signaling , 2002, Cell.
[52] C. Grimm,et al. HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration , 2002, Nature Medicine.
[53] N. Van Rooijen,et al. Improved Innate Immunity of Endotoxin-Tolerant Mice Increases Resistance to Salmonella enterica Serovar Typhimurium Infection despite Attenuated Cytokine Response , 2001, Infection and Immunity.
[54] David Brink,et al. : A Review of the , 2018 .
[55] F. Venet,et al. Monitoring Immune Dysfunctions in the Septic Patient: A New Skin for the Old Ceremony , 2008, Molecular medicine.
[56] M. Tomic-Canic,et al. The Role of Vascular Endothelial Growth Factor in Wound Healing , 2022 .